The main reasons for the failure of ICB in PDAC are the low proportion of tumor infiltrating PD-1+ T cells [63,128] and the paucity of neoepitopes [129,130], both of which can predict response to PD-1 blockade in other solid tumors [131,132]. The gene discussed is PDCD1; the disease is neoplasm.